Mark Duxon

Mark Duxon PhD is currently serving as the CEO of Transpharmation Ltd, CEO of InterVivo Solutions, and CEO of Vivocore Inc. Prior to these roles, Mark has held various executive positions in companies such as Porsolt, Maccine, GlaxoSmithKline, Synaptic Pharmaceutical Corp, SmithKline Beecham, and Merck Sharp and Dohme. Mark holds a Doctor of Philosophy (PhD) in Neuropharmacology from the University of Nottingham, where he also obtained a Bachelor of Science (BSc) in Molecular Biology.